Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Amsterdam UMC Research BV in the Netherlands seeks a highly motivated researcher to design and execute proteomics studies on human brain tissue and iPSC-derived neurons to understand cell-type-specific vulnerability in Frontotemporal dementia (FTD).
You will contribute to translational neuroscience through advanced single-cell and spatial omics technologies and participate in scientific reporting and publications.
Organisation/Company Amsterdam UMC Research Field Neurosciences » Neurobiology Neurosciences » Neurochemistry Researcher Profile First Stage Researcher (R1) Application Deadline 15 Nov 2026 - 22:59 (UTC) Country Netherlands Type of Contract Temporary Job Status Not Applicable Hours Per Week 36.0 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No
Frontotemporal dementia (FTD) encompasses a group of neurodegenerative diseases that progressively affect behavior, movement, personality and/or language. We aim to identify the molecular and cellular causes of FTD that trigger its onset and early progression with the aim to design evidence-based treatment.
We are looking for a highly motivated researcher to join our team. You will design and execute proteomics studies on human brain tissue of sporadic patients and human iPSC-derived neurons. The aim is to understand the molecular and cellular dysfunctions that lead to cell-type-specific vulnerability that may be causative to FTD through highly innovative single-cell and spatial (prote)-omics technologies.
Would you like to know more about the different phases within the PhD trajectory? You can read more about this on this page .
As a member of our team, you will:
This position offers a unique opportunity to contribute to translational neuroscience in a dynamic team of proteomic and neuroscience researchers in the search for fundamental insights with real-world therapeutic impact. You have:
We are looking for the following personality traits:
Watch this video with more information about joining Amsterdam UMC Research BV.
Additional comments
During the publication period, applications will be handled continuously. If the vacancy is filled, it will be closed prematurely.
The first round of interviews is scheduled for November 24, 2026. The second round of interviews is scheduled for December 15, 2026.
If you have any questions about this position, please feel free to contact Claudia Ctortecka, SCAPE Unit Lead, via c.c.ctortecka@amsterdamumc.nl .
A reference check, screening and hiring assessment may be part of the procedure. Read here whether that applies to you. If you join us, we ask you for a VOG (Certificate of Good Conduct).
Internal candidates will be given priority over external candidates in case of equal suitability.
Acquisition in response to this vacancy will not be considered.